Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced peripheral ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Advertisement "Our findings emphasize that chronic painful chemotherapy-induced peripheral neuropathy represents a substantial global health challenge, affecting more than 40% of those diagnosed ...

Trusted resource of information on Medical Oncology that includes articles, news, diet & nutrition, multimedia presentations, ...

“Our findings emphasize that chronic painful chemotherapy-induced peripheral neuropathy represents a substantial global health challenge, affecting more than 40% of those diagnosed,” concluded ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might ...